Go Pro
OTCMKTS:CVALF

Covalon Technologies Q2 2026 Earnings Report

Covalon Technologies logo
$2.95 -0.25 (-7.70%)
As of 09/29/2026 02:45 PM Eastern

Covalon Technologies EPS Results

Actual EPS
$0.03
Consensus EPS
$0.01
Beat/Miss
Beat by +$0.02
One Year Ago EPS
N/A

Covalon Technologies Revenue Results

Actual Revenue
$6.27 million
Expected Revenue
$6.70 million
Beat/Miss
Missed by -$422.00 thousand
YoY Revenue Growth
N/A

Covalon Technologies Announcement Details

Quarter
Q2 2026
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Covalon Technologies' next earnings date is estimated for Thursday, December 10, 2026, based on past reporting schedules.

Conference Call Resources

Covalon Technologies Earnings Headlines

Covalon Reports Fiscal 2026 Third Quarter Results
Covalon Technologies Ltd CVALF
Why I went to Mount Rushmore
A small miner just hit on gold in the hills surrounding Mount Rushmore, thanks to a breakthrough new technology. This could be one of the biggest gold finds since the 1870s, yet the stock still trades around 6 dollars. BlackRock and Vanguard have been quietly loading up on shares while most investors have missed the story. The same technology is unlocking hidden resource wealth across America, driving stocks up 227 percent, 378 percent, and even 773 percent.tc pixel
Covalon Reports 2026 Second Quarter Results
See More Covalon Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Covalon Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Covalon Technologies and other key companies, straight to your email.

About Covalon Technologies

Covalon Technologies (OTCMKTS:CVALF) is a Canadian medical technology company focused on developing and commercializing advanced healthcare products. Its activities center on wound care, infection prevention and surgical applications, with technologies designed to help protect tissue, support healing and improve the management of medical procedures.

The company’s product portfolio includes collagen-based wound care products marketed under the ColActive brand, as well as antimicrobial and protective coatings, dressings and other medical devices. Covalon develops technologies for use in hospitals, clinics and other healthcare settings, including products intended to address chronic wounds, surgical wounds and infection-control needs.

Covalon serves healthcare providers and patients through commercial relationships with distributors and medical organizations in North America and selected international markets. The company is headquartered in Canada and has historically operated as a publicly traded healthcare technology business under the Covalon name.

View Covalon Technologies Profile